Holen Sie sich die Stockscreener-App
9.99
15.84%
-1.88
Handel nachbörslich:
9.92
-0.07
-0.70%
Schlusskurs vom Vortag:
$11.87
Offen:
$11.84
24-Stunden-Volumen:
5.29M
Relative Volume:
5.44
Marktkapitalisierung:
$1.09B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-227.05M
KGV:
-4.5409
EPS:
-2.2
Netto-Cashflow:
$-177.93M
1W Leistung:
-16.75%
1M Leistung:
-10.08%
6M Leistung:
+32.67%
1J Leistung:
+17.39%
1-Tages-Spanne:
$9.3702
$11.98
1-Wochen-Bereich:
$9.3702
$12.30
52-Wochen-Spanne:
$3.67
$12.61
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
Cogent Biosciences (NASDAQ:COGT) Shares Down 5.3%What's Next? - MarketBeat
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting - The Manila Times
Cogent Biosciences to Present Key Bezuclastinib Trial Data at ASH 2024 Meeting | COGT Stock News - StockTitan
Cogent Biosciences' (COGT) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.67 Average PT from Brokerages - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
(COGT) Investment Analysis - Stock Traders Daily
Hennion & Walsh Asset Management Inc. Purchases 44,287 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences' (COGT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Cogent Biosciences expands pipeline with KRAS inhibitor - Investing.com
Cogent Biosciences expands pipeline with KRAS inhibitor By Investing.com - Investing.com UK
Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics - StockTitan
Cogent Biosciences Announces Pipeline Expansion into KRAS - GlobeNewswire
COGT Stock Hits 52-Week High at $12.2 Amid Market Optimism - Investing.com India
Cogent Biosciences (NASDAQ:COGT) Sets New 52-Week HighHere's What Happened - MarketBeat
Here's Why We're Not Too Worried About Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation - Yahoo Finance
SG Americas Securities LLC Acquires New Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
The Manufacturers Life Insurance Company Has $301,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Market Momentum Report: Cogent Biosciences Inc (COGT)’s Negative Close at 11.35 - The Dwinnex
Cogent Biosciences (NASDAQ:COGT) Shares Down 2.4%What's Next? - MarketBeat
(COGT) Technical Data - Stock Traders Daily
Stocks of Cogent Biosciences Inc (COGT) are poised to climb above their peers - SETE News
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.6%Here's What Happened - MarketBeat
Did Cogent Biosciences Inc (COGT) perform well in the last session? - US Post News
Analysts Rate Cogent Biosciences, Inc. (COGT) as Moderate Buy with $15 Target - Insider Monkey
Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - SETE News
Metric Deep Dive: Understanding Cogent Biosciences Inc (COGT) Through its Ratios - The Dwinnex
Dimensional Fund Advisors LP Has $7.84 Million Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
(COGT) On The My Stocks Page - Stock Traders Daily
American Century Companies Inc. Sells 7,032 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Algert Global LLC - Defense World
Algert Global LLC Sells 207,078 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2% - MarketBeat
A better buy-in window may exist right now for Cogent Biosciences Inc (COGT) - SETE News
Can Cogent Biosciences Inc (COGT) meet market expectations this quarter? - US Post News
Insider’s View: Deciphering Cogent Biosciences Inc (COGT)’s Financial Health Through Ratios - The Dwinnex
Cogent Biosciences, Inc. (NASDAQ:COGT) Short Interest Update - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by SkyView Investment Advisors LLC - Defense World
Cogent Biosciences: Need To Wait For More Data For Adequate Differentiation (NASDAQ:COGT) - Seeking Alpha
Point72 Asset Management L.P. Has $88.27 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Forefront Analytics LLC Sells 3,648 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Profund Advisors LLC Sells 73,992 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
It makes sense and dollars to buy Cogent Biosciences Inc (COGT) stock - SETE News
Deerfield Management Company L.P. Series C Grows Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences Inc (COGT) deserves closer scrutiny - US Post News
Point72 Asset Management L.P. Raises Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Point72 Asset Management L.P. Acquires 8,310,150 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Croda International (OTCMKTS:COIHD) Sets New 52-Week Low at $26.75 - Defense World
Corcept Therapeutics (NASDAQ:CORT) Sets New 52-Week High at $43.81 - Defense World
The time has not yet come to remove your chips from the table: Coherent Corp (COHR) - SETE News
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.02%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):